Study: Shingles vaccine is effective for seniors but few get it

04/10/2013 | HealthDay News

An analysis of data from more than 700,000 Medicaid beneficiaries found that the shingles vaccine is effective at reducing the risk of shingles and post-herpetic neuralgia, but only 4% in the study group received it. The vaccine reduced the rate of shingles by 48% and post-herpetic neuralgia by 59% overall. The study appeared in the journal PLoS Medicine.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC